Clinical Kidney Journal

Article	Citations
Obinutuzumab treatment for membranous nephropathy: effectiveness and safety concerns during the COVID-19 pandemic	462
Toward acid- and heparin-free dialysis: the regional anticoagulation approach	112
Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study	91
Can exercise improve outcomes for frail haemodialysis patients?	89
Interaction of general obesity and abdominal obesity with frailty in patients with chronic kidney disease: a nationally representative analysis	72
Use of eHealth and remote patient monitoring: a tool to support home dialysis patients, with an emphasis on peritoneal dialysis	57
Associations between depressive symptoms and disease progression in older patients with chronic kidney disease: results of the EQUAL study	56
Impact of the COVID pandemic on vascular access creation for haemodialysis in 16 Spanish haemodialysis centres	55
Correction to: Accelerated versus watchful waiting strategy of kidney replacement therapy for acute kidney injury: a systematic review and meta-analysis of randomized clinical trials	50
Probability of chronic kidney disease and associated risk factors in Chinese adults: a cross-sectional study of 9 million Chinese adults in the Meinian Onehealth screening survey	49
Non-invasive assessment of IgA nephropathy severity with [18F]AlF-NOTA-FAPI-04 PET/CT imaging	48
Alleviating symptoms in patients undergoing long-term hemodialysis: a focus on chronic kidney disease-associated pruritus	45
Association between frailty and bone health in early-stage chronic kidney disease: a study from the population-based CARTaGENE cohort	44
Informal caregiver burden in dialysis care and how it relates to patients’ health-related quality of life and symptoms	43
Efficacy and safety of telitacicept, a BLyS/APRIL dual inhibitor, in the treatment of IgA nephropathy: a retrospective case–control study	40
More dissimilarities than affinities between DNAJB11-PKD and ADPKD	39
A puzzling renal Fanconi Syndrome	38
Risk factors for steroid-induced osteonecrosis of the femoral head in children with immune kidney disease	34
Clinically meaningful eGFR slope as a surrogate endpoint differs across CKD stages and slope evaluation periods: the CKD-JAC study	34
Causal relationships between immune cell phenotypes and primary glomerular diseases: genetic evidence from bidirectional Mendelian randomization study	32
Meet and greet but avoid the heat: a reflection on the carbon footprint of congresses prompted by ERA2023	32
The spectrum of diseases, genetic landscape and new mutation sites of hereditary cystic kidney disease	32
Plant-based diets for CKD patients: fascinating, trendy, but feasible? A green nephrology perspective	32
The use of SGLT2 inhibitors and GLP-1 receptor agonists in older patients: a debate on approaches in CKD and non-CKD populations	31
Biomarkers in clinical epidemiology studies	30

Performance of the race-free CKD-EPI creatinine-based eGFR equation in a Danish cohort with measured GFR	29
Standardization of serum creatinine is essential for accurate use of unbiased estimated GFR equations: evidence from three cohorts matched on renal function	29
Donor-derived membranous nephropathy	29
Circulating miR-129-3p in combination with clinical factors predicts vascular calcification in hemodialysis patients	28
Successful treatment of calciphylaxis with vitamin K in a patient on haemodialysis	28
Cerebral blood flow following successful living kidney transplantation: the VINTAGE study	28
Machine learning models for predicting acute kidney injury: a systematic review and critical appraisal	27
Prolonged detection of SARS-CoV-2 RNA in chronic haemodialysis patients	27
Differentiating primary and secondary FSGS using non-invasive urine biomarkers	27
Glomerular endothelial injury following vaccination for SARS-CoV-2	27
Risk factors for acute kidney injury and kidney relapse in patients with lupus podocytopathy	27
Robot-assisted kidney transplantation: an update	27
Safety and efficacy of glucagon-like peptide-1 receptor agonists among kidney transplant recipients: a systematic review and meta-analysis	27
Urinary peptide signature distinguishes autosomal recessive polycystic kidney disease from other causes of chronic kidney disease	26
Prevalence and outcomes of chronic liver disease in patients receiving dialysis: systematic review and meta-analysis	26
Cardiometabolic protein expression levels and pathways associated with kidney function decline in older European adults with advanced kidney disease	26
Addressing cognitive impairment in peritoneal dialysis: a systematic review and meta-analysis of prevalence, risk factors, and outcomes	26
Self-limited, sodium-dependent osmotic diuresis causes polyuria after living donor kidney transplantation	25
Effects of anti-inflammatory agents on clinical outcomes in people with chronic kidney disease: a systematic review and meta-analysis of randomized control trials	25
Kidney Donor Profile Index and allograft outcomes: interactive effects of estimated post-transplant survival score and ischaemic time	25
Should we enlarge the indication for kidney biopsy in patients with diabetes? The pro part	24
The impact of gender on the risk of cardiovascular events in older adults with advanced chronic kidney disease	24
Troponin I is an independent predictor of cardiovascular events and mortality in haemodialysis patients	24
Glycemic control and complications in hemodialysis patients: the TURK-HEMODIAB STUDY	24
Elevated RHAMM as a biomarker for predicting diabetic kidney disease in patients with type 2 diabetes	23
Epidemiological risk factors for acute kidney injury outcomes in hospitalized adult patients: a multicenter cohort study	23
Association between cause of kidney failure and fracture incidence in a national US dialysis population cohort study	23
Introduction to new CKJ section: In Context – in collaboration with YNP	23
Treatment of acute kidney injury in cancer patients	23
Integrating electronic health data records to develop and validate a predictive model of hospital-acquired acute kidney injury in non-critically ill patients	22
Kidney hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in diabetes: physiology and clinical implications	22
Lower serum magnesium levels are associated with a higher risk of fractures and vascular calcifications in hemodialysis patients	22
Comparison of safety and outcomes related to remdesivir treatment among dialysis patients hospitalized with COVID-19	22
Complications on the feeding artery after an arterio-venous fistula closure in patients after kidney transplantation – a national cohort study	22
Visit-to-visit variability in blood pressure and kidney disease progression in IgA nephropathy	22
A small circulating miRNAs signature predicts mortality and adverse cardiovascular outcomes in chronic hemodialysis patients	21
Soluble urokinase plasminogen activator receptor and decline in kidney function among patients without kidney disease	21
The effect of sevelamer on serum calcification propensity in patients with chronic kidney disease: the results of a multicentre, double-blind, placebo-controlled, randomized clinical trial	21
Strategies to prevent SARS-CoV-2 transmission in hemodialysis centres across Europe—lessons for the future	20
CD44-negative parietal–epithelial cell staining in minimal change disease: association with clinical features, response to corticosteroids and kidney outcome	20
Novel loss-of-function mutations in TNFAIP3 gene in patients with lupus nephritis	20
Association between beta-blocker utilization and heart failure mortality in the peritoneal dialysis population: a cohort study	20
Renal function is highly associated with podiatric risk in diabetic patients	20
The integrated care model: facilitating initiation of or transition to home dialysis	20
Denosumab-induced hypocalcemia in patients treated with dialysis: an avoidable complication?	20
Cerebral white matter injury in haemodialysis patients: a cross-sectional tract-based spatial statistics and fixel-based analysis	20
Treatment of primary hyperoxaluria type 1	20
The Many Faces of NELL1 MN	19
Coordinating efforts to optimize next-generation kidney replacement therapies: the European Kidney Health Alliance Work Group ‘Breakthrough Innovation’	19
Evolving spectrum but persistent high mortality of COVID-19 among patients on kidney replacement therapy in the vaccine era: the Spanish COVID-19 KRT Registry	19

Genetic and clinical characterization of familial renal glucosuria	19
International validation of a pre-transplant risk assessment tool for graft survival in pediatric kidney transplant recipients	19
Wasp stings and plasma exchange	18
Personalizing electrolytes in the dialysis prescription: what, why and how?	18
Humoral and cellular immunogenicity of a fourth dose BNT162b2 in children with chronic kidney diseases	18
Sodium glucose co-transporter 2 inhibitors in the treatment of glomerular diseases: a CKJ controversy	18
Genetic testing in focal segmental glomerulosclerosis: in whom and when?	18
Precision medicine for the treatment of glomerulonephritis: a bold goal but not yet a transformative achievement	18
Estimating 24-Hour Urine Phosphate Excretion from Spot Urine	18
The role of low health literacy in shared treatment decision-making in patients with kidney failure	18
Chronic prescription of antidepressant medication in patients with chronic kidney disease with and without kidney replacement therapy compared with matched controls in the Dutch general population	18
How common is hyperkalaemia? A systematic review and meta-analysis of the prevalence and incidence of hyperkalaemia reported in observational studies	18
The assessment of hypertension in kidney transplant patients: time to change our approach?	18
Multiomic profiling of new-onset kidney function decline: insights from the STANISLAS study cohort with a 20-year follow-up	18
Endothelin receptor antagonists in diabetic and non-diabetic chronic kidney disease	18
The burden of hyperkalaemia in chronic kidney disease: a systematic literature review	18
Partnering with patients and caregivers to enrich research and care in kidney disease: values and strategies	18
Fatigue across different chronic kidney disease populations: experiences and needs of patients	18
Sugar-sweetened beverage consumption and mortality of chronic kidney disease: results from the US National Health and Nutrition Examination Survey, 1999–2014	17
Probiotics for kidney disease	17
Association of renin–angiotensin system blockers with COVID-19 diagnosis and prognosis in patients with hypertension: a population-based study	17
The impacts of hypoxia-inducible factor stabilizers on laboratory parameters and clinical outcomes in chronic kidney disease patients with renal anemia: a systematic review and meta-analysis	17
Development and internal validation of a Wasp Sting Severity Score to assess severity and indicate blood purification in persons with Asian wasp stings	17
Humoral responses to BNT162b2 SARS-CoV-2 and hepatitis B vaccines are associated in patients on maintenance hemodialysis: a single-centre experience in Belgium	17
Renal outcomes in immunoglobulin A nephropathy following COVID-19 vaccination: a retrospective cohort study	17
Early and late acute kidney injury: temporal profile in the critically ill pediatric patient	17
Urinary sediment CCL5 messenger RNA as a potential prognostic biomarker of diabetic nephropathy	17
Remote management of anaemia in patients with end-stage kidney disease using a wearable, non-invasive sensor	17
Integrating multiple kidney function markers to predict all-cause and cardiovascular disease mortality: prospective analysis of 366 758 UK Biobank participants	17
Prevalence, awareness, treatment, and control of hypertension in community-dwelling older adults with chronic kidney disease: the Irish longitudinal study on ageing	16
Potassium management and heart failure: a nephrologist's perspective	16
A 20-year follow-up study of identical twin sisters with immunoglobulin A nephropathy	16
Designing qualitative research with value in the clinical and epidemiological context: what, why and how	16
Valvular heart disease in patients on kidney replacement therapy: “opening Pandora's box”	16
Association of deprivation and its individual domains on outcomes in people with chronic kidney disease	16
Incidence of anti-glomerular basement membrane disease during the COVID-19 pandemic	16
From electronic health records to clinical management systems: how the digital transformation can support healthcare services	15
Comparative analysis of tools to predict rapid progression in autosomal dominant polycystic kidney disease	15
Dynamic prediction of kidney allograft and patient survival using post-transplant estimated glomerular filtration rate trajectory	15
Automating kidney transplant rejection diagnosis: a simple solution for a complex problem?	15
Multiparametric MRI: can we assess renal function differently?	15
Dapagliflozin in chronic kidney disease: cost-effectiveness beyond the DAPA-CKD trial	15
Peritoneal dialysis–first initiative in India: a cost-effectiveness analysis	15
Anti-phospholipid antibodies nephropathy is associated with an increased risk of kidney failure: a systematic literature review and meta-analysis	15
Machine learning models for mortality prediction in critically ill patients with acute pancreatitis–associated acute kidney injury	15
Integrative analysis of the association between circadian rhythm and lupus nephritis	15
Current practices in prevention, screening, and treatment of diabetes in kidney transplant recipients: European survey highlights from the ERA DESCARTES Working Group	15
Valvular calcification in chronic kidney disease: new insights from recent clinical and preclinical studies	15
Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association	15
Induction immunosuppression and outcome in kidney transplant recipients with early COVID-19 after transplantation	15
The effect of COVID-19 vaccination on kidney function and HLA antibody formation in patients with end-stage kidney disease and on kidney replacement treatment	15
Individualized everolimus treatment for tuberous sclerosis-related angiomyolipoma promotes treatment adherence and response	15
Leukopenia in autosomal dominant polycystic kidney disease: a single-center cohort of kidney transplant candidates with post-transplantation follow-up	15
Novel NUP160 mutations related to simultaneous congenital nephropathy and ovarian insufficiency	15
Collagen type III formation but not degradation is associated with risk of kidney disease progression and mortality after acute kidney injury	14
The role of blood purification therapies in the treatment of chronic kidney disease–associated pruritus: a systematic review	14
New aspects in cardiorenal syndrome and HFpEF	14
Renal involvement is frequent in adults with primary mitochondrial disorders: an observational study	14
Liver safety of tolvaptan in patients with autosomal dominant polycystic kidney disease: interim data from a post-authorization safety study	14
Differences in association between hypoalbuminaemia and mortality among younger versus older patients on haemodialysis	14
Management of hypertension in patients with cancer: challenges and considerations	14
Rituximab as a first-line therapy in children with new-onset idiopathic nephrotic syndrome	14
Novel equations for estimating intraperitoneal pressure among peritoneal dialysis patients	14
Cancer risks in people on dialysis and kidney transplant recipients: a Catalan cohort study, 2003–21	14
Use of nephrotoxic medications in adults with chronic kidney disease in Swedish and US routine care	13
New and old GFR equations: a European perspective	13
National Unified Renal Translational Research Enterprise: Idiopathic Nephrotic Syndrome (NURTuRE-INS) study	13
Performance of an interstitial glucose monitoring device in patients with type 1 diabetes during haemodialysis	13
Prescription patterns of sodium and calcium polystyrene sulfonate in patients with hyperkalemia and chronic kidney disease receiving RAAS inhibitors	13
Anticoagulation in patients with end-stage kidney disease and atrial fibrillation: a national population-based study	13
Ageing meets kidney disease	13
Longitudinal serum bicarbonate and mortality risk in older patients with advanced chronic kidney disease: analyses from the EQUAL cohort	13
New trials in resistant hypertension: mixed blessing stories	13
The Latin American Dialysis and Renal Transplantation Registry: report 2019	13
Decoy receptors as biomarkers for exploring aetiology and designing new therapies	13
Urinary soluble PD-1 as a biomarker of checkpoint inhibitor-induced acute tubulointerstitial nephritis	13
Correction to: Moving on obesity treatment in CKD: inertia is unjustified	13
Long-term effect of increasing water intake on repeated self-assessed health-related quality of life (HRQoL) in autosomal dominant polycystic kidney disease	13
Synergistic effect of teclistamab with PD-1 inhibition: a case of acute interstitial nephritis with dual immunotherapy	12
Nafamostat mesylate has advantages as an anticoagulant for patients undergoing maintenance hemodialysis with conjunctival bleeding	12

Defining diagnostic trajectories in patients with podocytopathies	12
A review of supportive care for older people with advanced chronic kidney disease	12
Cystatin C–based estimated GFR performs best in identifying individuals with poorer survival in an unselected Chinese population: results from the China Health and Retirement Longitudinal Study (CHARL	12
Mortality associated with the COVID-19 pandemic in the Swiss dialysis population beyond SARS-CoV-2 infection	12
The elevation of the anion gap in steady state chronic kidney disease may be less prominent than generally accepted	12
Real-world usage of Chronic Kidney Disease – Mineral Bone Disorder (CKD–MBD) biomarkers in nephrology practices	12
Are we ready for an adipocentric approach in people living with type 2 diabetes and chronic kidney disease?	12
Time-averaged concentration estimation of uraemic toxins with different removal kinetics: a novel approach based on intradialytic spent dialysate measurements	12
Reply to ‘Depression and clinical outcomes in CKD: do anti-depressants play a role? (EQUAL Study)’	12
Immobilization-associated hypercalcaemia in patients with malignancy in the hospital setting	12
Personalized peritoneal dialysis prescription—beyond clinical or analytical values	12
Prophylactic proton pump inhibitor usage and new-onset acute kidney injury in critically ill patients: a retrospective analysis	12
Trunk muscle quality and quantity are associated with renal volume in nondiabetic people	12
Twenty-four-hour proteinuria levels are associated with adverse pregnancy outcomes among women with CKD	12
Congestion as a crucial factor determining albuminuria in patients with cardiorenal disease	12
Mechanisms and treatment of obesity-related hypertension—Part 2: Treatments	12
The effect of a ketogenic diet on weight loss in CKD: a randomized controlled trial in obese stage G1–3a CKD patients	11
Association of albuminuria with incident atrial fibrillation in healthy older adults	11
Long-term outcomes of adults with FSGS in the German Chronic Kidney Disease cohort	11
A treasure from a barren island: the discovery of rapamycin	11
Incidence and prognosis of acute kidney injury versus acute kidney disease among 71 041 inpatients	11
Triglycerides–glucose index and the risk of cardiovascular events in persons with non-diabetic chronic kidney disease	11
Patterns of chronic and transient hyperkalaemia and clinically important outcomes in patients with chronic kidney disease	11
COVID-19 among kidney transplant recipients: evaluating risk factors during the initial phase of the pandemic	11
Cardiovascular risk prediction in hemodialysis patients using the triglyceride-glucose index: a multicenter prospective cohort study	11
Kidney–placenta crosstalk in health and disease	11
Hypoxia-inducible factor prolyl hydroxylase inhibitors in kidney transplant recipients	11
Lung ultrasonography performed by nephrologist: COVID-19 as an opportunity to reveal ultrasound's full potential and usefulness in the dialysis room	11
Association of urinary albumin:creatinine ratio with incident frailty in older populations	11
Prospective study of the effect of rituximab on kidney function in membranous nephropathy	11
Risk factors for major bleeding in patients with atrial fibrillation and CKD G3–G5D on oral anticoagulants	11
Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab	11
Incremental versus conventional haemodialysis in end-stage kidney disease: a systematic review and meta-analysis	11
Correlations, agreement and utility of frailty instruments in prevalent haemodialysis patients: baseline cohort data from the FITNESS study	11
Anti-nephrin antibody: a potential biomarker of minimal change disease	11
Antibody titers against SARS-CoV-2 spike protein 6 months after a third BNT162b2 vaccine in chronic hemodialysis patients	11
The ERA Registry Annual Report 2019: summary and age comparisons	11
Reply to ‘Stability and compatibility of antibiotics in PD solutions—call for including antibiotics for drug-resistant infections’	11
Malignancies and glomerulonephritis: when to suspect and when to screen?	11
Artificial intelligence to guide rituximab therapy in patients with phospholipase A2 receptor-associated membranous nephropathy	11
Cystatin C–based estimated glomerular filtration rate and risk of stroke in the general population: a prospective cohort study	10
The long-term benefits of early intensive therapy in chronic diseases—the legacy effect	10
Circulating metabolites associated with kidney function decline and incident CKD: a multi-platform population-based study	10
Kidney replacement therapy patients with COVID-19 in the vaccine era: what do we need to know?	10
Bone mineral density after exercise training in patients with chronic kidney disease stages 3 to 5: a sub-study of RENEXC—a randomized controlled trial	10
Prophylactic ultra-low dose rituximab to maintain remission in relapsing adult minimal change disease	10
Glomerular diseases post-hematopoietic stem cell transplantation: pathologic spectrum and plausible mechanisms	10
ERA Registry Figure of the month Expected remaining years of life for dialysis and kidney transplant patients	10
Matrix Gla protein polymorphism rs1800802 is associated with atheroma plaque progression and with cardiovascular events in a chronic kidney disease cohort	10
Chronic kidney disease duration and suicide risk among maintenance hemodialysis patients in China	10
Ionized and total magnesium levels in patients with chronic kidney disease: associated factors and outcomes	10
Correction to: Using artificial intelligence to predict mortality in AKI patients: a systematic review/meta-analysis	10
Contemporary outcomes of anemia in US patients with chronic kidney disease	10
The risk of CKD progression remains high in patients treated with ACE inhibitors and ARBs, MRAs and SGLT2 inhibitors. Have we already achieved the therapeutic ceiling in CKD? (The CON part)	10
Do you feel itchy? A guide towards diagnosis and measurement of chronic kidney disease-associated pruritus in dialysis patients	10
Associations between iron markers with hemoglobin and outcomes in peritoneal dialysis patients: results from the PDTAP study	10
Quantifying the potential contribution of drugs to the occurrence of acute kidney injury in patients with chronic kidney disease	10
The effect of standard percutaneous nephrolithotomy, miniaturized percutaneous nephrolithotomy and retrograde intrarenal surgery on biomarkers of renal injury: a randomized clinical trial	10
Disturbance in the potential cardiovascular–bone–skeletal muscle axis and morbidity and mortality in patients undergoing haemodialysis: the Q-Cohort Study	10
Albuminuria after induction treatment and kidney prognosis in ANCA-associated glomerulonephritis	10
C5a receptor inhibitor avacopan in immunoglobulin A nephropathy—an open-label pilot study	10
Estimation of glomerular filtration rate in cardiorenal patients: a step forward	10
An update on absolute and relative indications for dialysis treatment modalities	10
Activation of the inflammasome and pyroptosis cascade in podocytes of patients with minimal change disease	10
History of creatinine clearance: tribute to a forerunner	10
Pre-emptive use of glucose 5% as the standard drug solvent reduces hypernatremia in critically ill patients	9
Urine complement-related proteins in IgA nephropathy and IgA vasculitis nephritis, possible biomarkers of disease activity	9
Association of secondary prevention medication use after myocardial infarction with mortality in hemodialysis patients	9
Single-nephron assessment of urate excretion in patients with IgA nephropathy	9
Central volume shift in acute heart failure revealed by blood volume monitoring during haemodialysis	9
Mortality and disability-adjusted life years in North Africa and Middle East attributed to kidney dysfunction: a systematic analysis for the Global Burden of Disease Study 2019	9
Primary hyperoxaluria: the adult nephrologist's point of view	9
Association of metabolic acidosis with fractures, falls, protein-calorie malnutrition and failure to thrive in patients with chronic kidney disease	9
31P-MRS, molecular level imaging for assessing muscular mitochondrial dysfunction in chronic kidney disease	9
The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term outcome	9
Qualitative approach to better understand the trajectory of patients with early and moderate stage CKD	9
Antibody maintenance and breakthrough infections 6 months after complete COVID-19 vaccination with the mRNA-1273 and BNT162b2 vaccines in hemodialysis patients	9
A pre-transplantation risk assessment tool for graft survival in Dutch pediatric kidney recipients	9
Outcomes of patients with COVID-19 on kidney replacement therapy: a comparison among modalities in England	9
The impact of mild and moderate COVID-19 infection on the progression of kidney dysfunction in patients with IgA nephropathy	9
Unraveling complexity: morbidity factors in elderly kidney transplant recipients	9
Cancer among kidney transplant recipients >20 years after transplantation: post-transplant lymphoproliferative disorder remains the most common cancer type in the ultra long-term	9
Trial design of the MOTheR HDx study: a multicenter, open-label, prospective, randomized study to explore the morbidity and mortality in patients dialyzed with the Theranova HDx in comparison with onl	9
The effects of a physical exercise program in Chinese kidney transplant recipients: a prospective randomised controlled trial	9
Measures of wave intensity as a non-invasive surrogate for cardiac function predicts mortality in haemodialysis patients	9
Push toward pre-emptive kidney transplantation – for sure?	9
Should we continue to use renin–angiotensin–aldosterone system blockers in patients with COVID-19?	9
Long-Term Evaluation of the Timing of Corticosteroid Therapy in an IgA Nephropathy Cohort	9
Efficacy and safety of finerenone in IgA nephropathy: an observational multicentre study	9
Cystatin C or creatinine for pre-operative assessment of kidney function and risk of post-operative acute kidney injury: a secondary analysis of the METS cohort study	9
Compound heterozygous variants of ANKFY1 in a child with infantile-onset proteinuria and movement disorder	9
Development and validation of a measure to assess patient experience of needling of arteriovenous fistulas or grafts for haemodialysis access: the NPREM	9
Management of de novo nephrolithiasis after kidney transplantation: a comprehensive review from the European Renal Association CKD-MBD working group	9
Acute kidney injury after non-cardiac major surgery: has it reduced?	9
Association of serum bicarbonate with the development of kidney stones in patients with chronic kidney disease: a retrospective cohort study	9